Xu Haoyu of Yangtze River Pharmaceutical Group: Working with partners to navigate the new economic cycle
2024-08-11
한어Русский языкEnglishFrançaisIndonesianSanskrit日本語DeutschPortuguêsΕλληνικάespañolItalianoSuomalainenLatina
Yangzi Evening News Network reported on August 11 (correspondent Yang Wen, reporter Wang Guozhu) On August 10, the 17th Health Industry (International) Ecological Conference (hereinafter referred to as "Xipu Conference") opened in Boao, Hainan. The conference was themed "Moving forward under pressure - breaking and establishing from stock to increment", and gathered more than 8,000 representatives from the pharmaceutical industry, retail pharmacies and other sectors to discuss the incremental space of the health industry in the stock era. As a representative of the pharmaceutical industry, Xu Haoyu, Secretary of the Party Committee, Chairman and President of Yangtze River Pharmaceutical Group, was invited to give the opening keynote speech "53 years of pursuit and progress, Yangtze River and you work together to forge ahead and cross the new economic cycle together".
According to the forecast data of Zhongkang Industry Research Institute, the growth rate of all drug terminals is expected to drop to 4.9% in 2024, and the growth rate of drug categories in physical pharmacies is expected to be only 2.9% throughout the year. Faced with this situation, Xu Haoyu believes that we should combine national policies and user needs, promote the big health industry in an orderly manner, build a diversified health service system, and achieve breakthroughs in continuously meeting the diverse health needs of the public.
Xu Haoyu
Seize opportunities in crises and create new situations in changing situations
In recent years, my country's total health expenditure has continued to increase, accounting for 7.0% of GDP in 2023, which is still behind developed countries such as the United States, Japan, the United Kingdom, and Germany. However, dialectically speaking, my country's population is far larger than that of developed countries, and the base of the elderly population is increasing year by year. Health management cannot simply copy the practices and experiences of Europe and the United States.
Healthy China is not only achieved by "treating existing diseases", but also by scientific and correct health concepts and maintaining a healthy lifestyle. Xu Haoyu believes that moving the prevention threshold forward will save the overall social cost and reduce the suffering of patients. All parties should combine health needs, apply Chinese wisdom, and work together to explore a healthy path with Chinese characteristics of "preventing diseases before they occur".
Based on in-depth insights into healthy consumer demand, Yangtze River Pharmaceutical has created a new track for qi-replenishing Chinese medicine products, with Longfengtang Astragalus Essence as its flagship product, targeting typical groups such as those suffering from qi deficiency, and cooperating with retail pharmacies to optimize, strengthen and expand its product line through a combination of 100,000 urban qi-replenishing station activities, 100,000 standardized displays in stores, 50,000 professional trainings and consumer tasting sessions, and enabling channel partners to achieve incremental growth.
In order to fully meet the health consumption needs of users, Yangtze River Pharmaceutical will also focus on developing health products with unique functions and advantages. In the research of "Natto Red Yeast Capsules", AI technology is used to study the activity of nattokinase, more accurately evaluate the effect of nattokinase, and achieve quantitative management. This achievement will also be applied to the health management of retail pharmacies in the future, benefiting hundreds of millions of people with carotid artery plaques.
Xu Haoyu said that through a wide-ranging product layout, it is possible to fully meet the diverse needs of different consumers, provide retail pharmacies with a one-stop solution, and help retail pharmacies increase their confidence in working together for development.
At present, Yangtze River Pharmaceutical has developed 5 products with a scale of more than 1 billion yuan, 43 varieties with a scale of more than 100 million yuan, 47 exclusive products, 128 medical insurance products, and 87 products under development. It can be said that Yangtze River Pharmaceutical has formed a "carrier battle group" of considerable size in the stock market, with sufficient "ammunition" to support channel partners; it has also actively laid out in the incremental market to form a "combination punch".
Health Marketing, Marketing Health
On August 3, the "Opinions of the State Council on Promoting the High-quality Development of Service Consumption" was issued, which clearly proposed to cultivate and expand new consumption, including healthy consumption. It also proposed to strengthen the health promotion, nutrition and health care functions of retail pharmacies. Xu Haoyu believes that the current "solution" for retail pharmacies lies in this.
Production and circulation are essentially for the service of consumption. Only by truly putting ourselves in the shoes of users and even exceeding their expectations can we remain invincible in the new economic cycle. Only by focusing on national requirements and residents' needs, seizing opportunities and meeting challenges can we truly solve the pain points in the current development of retail pharmacies.
In his speech, Xu Haoyu first proposed the concept of "health marketing, marketing health", that is, to help end users achieve their health goals and improve their quality of life through health products and services that exceed expectations, to help achieve the transformation from "treatment-centered" to "people-centered health", and to continuously enhance the people's sense of gain, happiness and security.
In practice, Yangtze River Pharmaceutical has summarized the four dimensions that need to be followed in "healthy marketing, marketing health". From the perspective of drug circulation, compliance is the prerequisite, and every link of drug circulation is ensured to be safe and reliable through system compliance and risk control; confidence is the key, empowering the circulation terminal with excellent product quality and a complete product matrix; traffic is the guarantee, strengthening the industry's value-leading function in the popular science end, and promoting "real traffic" through precise marketing; profit is the foundation, creating a new path for profit growth and providing new guarantees for profit sharing.
According to reports, Yangtze River Pharmaceutical has recently carried out 425 "Microcirculation Patch" public welfare activities, continuously tracked and collected more than 5,300 consumer sample data, driving a 27% week-on-week increase in the number of consumers and a 28% week-on-week increase in store sales. In the "Ten Thousand Doctors Entering Stores" public welfare activity, Yangtze River Pharmaceutical integrated high-quality resources to widely empower pharmacy terminals, which not only facilitated local residents, but also improved the reputation and traffic of stores.
Xu Haoyu said that Yangtze River Pharmaceutical will start from the needs of consumers, formulate personalized and professional service plans, and continuously bring more "certainty" to the channel.
Xu Haoyu further stated that he would work with partners to adhere to long-termism, create a multi-coverage health industry ecosystem across the entire industry chain, and build a complete omni-channel marketing system with more than 18,000 employees. He would work with partners to cross the new economic cycle and continue to increase value while satisfying the people's aspirations for a healthy life.
Proofread by Xu Heng
